Crispr-Edited Pancreatic Cells Successfully Transplanted in Type 1 Diabetes Patient for the First Time
Gene-edited pancreatic cells have been transplanted into a patient with type 1 diabetes for the first time. They produced insulin for months without the patient needing to take immunosuppressants.
Read the full articleYou might also wanna read
New first-in-human study explores immune-engineered cell therapy approach for type 1 diabetes
New research presented at the International Society for Stem Cell Research (ISSCR) 2026 Annual Meeting explores an approach that could expan
New first-in-human study explores immune-engineered cell therapy ...
The study addresses one of the field's central challenges: overcoming immune rejection, which has limited the broader use of islet and stem
First Human Trial Explores Immune-Engineered Cell Therapy for Type 1
A groundbreaking study unveiled at the International Society for Stem Cell Research (ISSCR) 2026 Annual Meeting marks a pivotal advancement
Oxford surgeons in world-first breakthrough for pancreas transplants
Researchers at the University of Oxford have successfully transplanted the first perfused human pancreas using a new preservation technique.
Experimental stem cell treatment can cure severe type 1 diabetes
Interview with Tuncay Delibasi, MD
World-first perfused pancreas transplant marks major milestone
University of Oxford researchers have carried out the world’s first successful transplantation of a perfused human pancreas, a major advance
Comments
Sign in to join the conversation.
No comments yet. Be the first.